In the News

The Burrill Report interviews Greg Scott on WuXi/CRL breakup and China IPOs
 
Greg Scott joined Foley's Eye on China webinar on innovation
>>Foley webinar...

Event News

2nd Annual ChinaBio Partnering Forum attracts 558 attendees to Suzhou... more >>

ChinaBio® Events

BioBay Investor Forum 2010

Suzhou, China

Nov. 3-4, 2010

China Forum 2010

Munich, Germany

November 14, 2010

ChinaBio® Investor Forum 2010 - Guangzhou

Guangzhou, China

December 21, 2010

Latest Headlines

ChinaBio® Today

Free Newsletter

ChinaBio® Today
Email address:

Partner Events

BioPharm America™ 2010

Boston, MA, USA

September 15–17, 2010

CALAsia 2010

San Diego, USA

October 4-5, 2010

Partners

Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners

Consulting

ChinaBio® Consulting is focused exclusively on the life science industry in China. We work with established and emerging biotechnology, medical device and diagnostics companies with operations in China, or seeking to do business in China or with Chinese companies.   Clients have included Pfizer, Roche, LIfe Technologies (Invitrogen/ABI), Genentech, Humana and a number of early and mid-stage China biotechs and pharmas.

ChinaBio® Consulting assists China life science companies with their business strategy, funding and U.S. connections, and we help U.S. companies with their China strategies, competitive analyses, technology searches and China connections. We also assist top tier venture capitalists and investment funds with their China portfolios.  

Here are some examles of how we have helped some of our clients:

Our Clients
Our Services
U.S.
Life Science
Companies
China strategy
Competitive market analysis
Technology survey/search
Partnering arrangements
China build/operate/transfer
China
Life Science
Companies
Business strategy
Funding assistance
Partnering arrangements
Collaboration agreements
In-licensing/out-licensing
U.S. operations
Venture Capitalists and
Investment Funds
China strategy
Investment analysis
Due diligence
Portfolio analysis

ChinaBio®  is a highly flexible and collaborative firm that is easy to work with. We structure each engagement to best suit our client’s culture and the specialized needs of the engagement.

If you are a U.S. life science company looking to establish relationships or operations in China, or a China company seeking investors or partners in the U.S., ChinaBio® Consulting has the expertise and talent to help.

For more information, please contact us.